Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe

被引:43
作者
Rudzinski, Erin R. [1 ]
Kelsey, Anna [2 ]
Vokuhl, Christian [3 ]
Linardic, Corinne M. [4 ,5 ]
Shipley, Janet [6 ,7 ]
Hettmer, Simone [8 ]
Koscielniak, Ewa [9 ]
Hawkins, Douglas S. [10 ,11 ]
Bisogno, Gianni [12 ]
机构
[1] Seattle Childrens Hosp, Dept Labs, Seattle, WA 98105 USA
[2] Royal Manchester Childrens Hosp Manchester Fdn Tr, Dept Paediat Histopathol, Manchester, Lancs, England
[3] Univ Hosp Bonn, Dept Pathol, Sect Pediat Pathol, Bonn, Germany
[4] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA
[5] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA
[6] Inst Canc Res, Sarcoma Mol Pathol Team, Div Mol Pathol, London, England
[7] Inst Canc Res, Sarcoma Mol Pathol Team, Div Canc Therapeut, London, England
[8] Univ Freiburg, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, Univ Med Ctr Freiburg, Freiburg, Germany
[9] Klinikum Stuttgart, Olgahosp, Pediat Oncol Hematol Immunol 5, Stuttgart, Germany
[10] Univ Washington, Sch Med, Seattle Childrens Hosp, Canc & Blood Disorders Ctr, Seattle, WA USA
[11] Univ Washington, Sch Med, Dept Pediat, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[12] Univ Padua, Dipartimento Salute Donna & Bambino, Padua, Italy
关键词
pathology; pediatric; rhabdomyosarcoma; ALVEOLAR RHABDOMYOSARCOMA; FUSION STATUS; SCLEROSING RHABDOMYOSARCOMA; GENE; CLASSIFICATION; SPINDLE; COMMITTEE; AP2-BETA; MYOGENIN; TUMORS;
D O I
10.1002/pbc.28798
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The diagnosis and classification of rhabdomyosarcoma (RMS) has undergone several shifts over the last 30 years. While the main diagnostic categories remained the same, changes in the histologic criteria necessary for diagnosis, as well as varied reliance on immunohistochemical and molecular data over time, have created confusion, particularly regarding how these shifts impacted risk stratification and enrollment onto clinical trials. The goal of this report is to review the evolution and current status of RMS diagnosis, focusing on diagnostic criteria in the Children's Oncology Group (COG), the European Paediatric Soft Tissue Sarcoma Group (EpSSG), and the Cooperative Weichteilsarkom Studiengruppe (CWS). In addition, we emphasize research tools used to classify RMS and address biological questions within current clinical trials run by each group. The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT) initiative will maximize potential to optimize risk stratification by recognizing and accounting for differences in historical data and current practices.
引用
收藏
页数:10
相关论文
共 47 条
[1]   MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification [J].
Agaram, Narasimhan P. ;
LaQuaglia, Michael P. ;
Alaggio, Rita ;
Zhang, Lei ;
Fujisawa, Yumi ;
Ladanyi, Marc ;
Wexler, Leonard H. ;
Antonescu, Cristina R. .
MODERN PATHOLOGY, 2019, 32 (01) :27-36
[2]   Recurrent MYOD1 Mutations in Pediatric and Adult Sclerosing and Spindle Cell Rhabdomyosarcomas: Evidence for a Common Pathogenesis [J].
Agaram, Narasimhan P. ;
Chen, Chun-Liang ;
Zhang, Lei ;
LaQuaglia, Michael P. ;
Wexler, Leonard ;
Antonescu, Cristina R. .
GENES CHROMOSOMES & CANCER, 2014, 53 (09) :779-787
[3]   A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases [J].
Alaggio, Rita ;
Zhang, Lei ;
Sung, Yun-Shao ;
Huang, Shih-Chiang ;
Chen, Chun-Liang ;
Bisogno, Gianni ;
Zin, Angelica ;
Agaram, Narasimhan P. ;
LaQuaglia, Michael P. ;
Wexler, Leonard H. ;
Antonescu, Cristina R. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) :224-235
[4]   Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803 [J].
Arndt, Carola A. S. ;
Stoner, Julie A. ;
Hawkins, Douglas S. ;
Rodeberg, David A. ;
Hayes-Jordan, Andrea A. ;
Paidas, Charles N. ;
Parham, David M. ;
Teot, Lisa A. ;
Wharam, Moody D. ;
Breneman, John C. ;
Donaldson, Sarah S. ;
Anderson, James R. ;
Meyer, William H. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5182-5188
[5]   Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group [J].
Arnold, Michael A. ;
Anderson, James R. ;
Gastier-Foster, Julie M. ;
Barr, Frederic G. ;
Skapek, Stephen X. ;
Hawkins, Douglas S. ;
Raney, R. Beverly, Jr. ;
Parham, David M. ;
Teot, Lisa A. ;
Rudzinski, Erin R. ;
Walterhouse, David O. .
PEDIATRIC BLOOD & CANCER, 2016, 63 (04) :634-639
[6]   REARRANGEMENT OF THE PAX3 PAIRED BOX GENE IN THE PEDIATRIC SOLID TUMOR ALVEOLAR RHABDOMYOSARCOMA [J].
BARR, FG ;
GALILI, N ;
HOLICK, J ;
BIEGEL, JA ;
ROVERA, G ;
EMANUEL, BS .
NATURE GENETICS, 1993, 3 (02) :113-117
[7]   Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the intergroup rhabdomyosarcoma study-III trial - A report from the Children's Oncology Group [J].
Barr, FG ;
Smith, LM ;
Lynch, JC ;
Donna, S ;
Parham, DM ;
Qualman, SJ ;
Breitfeld, PP .
JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (02) :202-208
[8]  
Barr FG, 2002, CANCER RES, V62, P4704
[9]   HISTOPATHOLOGICAL CLASSIFICATION OF CHILDHOOD RHABDOMYOSARCOMA - A REPORT FROM THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY PATHOLOGY PANEL [J].
CAILLAUD, JM ;
GERARDMARCHANT, R ;
MARSDEN, HB ;
VANUNNIK, AJM ;
RODARY, C ;
REY, A ;
FLAMANT, F .
MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (05) :391-400
[10]   Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass [J].
Dias, P ;
Chen, B ;
Dilday, B ;
Palmer, H ;
Hosoi, H ;
Singh, S ;
Wu, C ;
Li, X ;
Thompson, J ;
Parham, D ;
Qualman, S ;
Houghton, P .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) :399-408